From longevity hype to clinical rigor
Andrea Maier argues that longevity medicine must adopt registries, randomized trials and global standards as clinics expand. She proposes mandatory core datasets, safety monitoring and a precision geromedicine registry in Singapore to link biological-age metrics to clinical outcomes.
Why it mattersCalls for a precision geromedicine registry and mandatory datasets (Singapore) mean regulators must design safety reporting and data standards.
People Mentioned
Andrea Maier